The store will not work correctly when cookies are disabled.
(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)(3-bromo-4,5-dihydroisoxazol-5-yl)methanone
ID: ALA4761568
PubChem CID: 162659426
Max Phase: Preclinical
Molecular Formula: C21H20BrCl2N3O2
Molecular Weight: 497.22
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(C1CC(Br)=NO1)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C21H20BrCl2N3O2/c22-19-13-18(29-25-19)21(28)27-11-9-26(10-12-27)20(14-1-5-16(23)6-2-14)15-3-7-17(24)8-4-15/h1-8,18,20H,9-13H2
Standard InChI Key: NUCJSENGDUANOF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
5.3474 -25.9745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9329 -25.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9329 -26.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3493 -24.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9354 -23.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1096 -23.8321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6994 -24.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1115 -25.2635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1089 -26.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6985 -27.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1090 -28.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9381 -28.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3489 -27.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6983 -23.1177 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6995 -28.8282 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.1723 -25.9745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5827 -26.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5827 -25.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4077 -25.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8222 -25.9745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6471 -25.9745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4077 -26.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0575 -25.2596 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0575 -26.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7224 -27.4425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3335 -27.9958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0485 -27.5854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8791 -26.7787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7975 -27.9210 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 1 0
27 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 497.22 | Molecular Weight (Monoisotopic): 495.0116 | AlogP: 4.72 | #Rotatable Bonds: 4 |
Polar Surface Area: 45.14 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.47 | CX LogP: 4.68 | CX LogD: 4.67 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.61 | Np Likeness Score: -1.14 |
References
1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142] [10.1016/j.bmcl.2020.127538] |